Veeva(US:VEEV) Prnewswire·2024-08-13 11:03Core Insights - The 2024 Veeva R&D and Quality Summit will feature industry leaders from major pharmaceutical companies to discuss advancements in drug development [1][2] - The event aims to enhance collaboration and innovation in the life sciences sector through connected systems across various functions [1][4] Group 1: Event Overview - The Veeva R&D and Quality Summit is one of the largest life sciences events, attracting over 2,000 executives and offering more than 100 sessions [2] - Veeva CEO Peter Gassner will deliver the opening keynote, focusing on how connected data and systems can streamline drug development and accelerate time to market [2] Group 2: Key Presentations - AbbVie and Merck will discuss the transformation of pharmacovigilance and its impact on operational visibility and efficiency [2][3] - Astellas will present its holistic approach to enhancing clinical processes for improved speed and transparency [3] - Eikon Therapeutics will highlight the importance of establishing a scalable foundation for efficient development from clinical trials to product launch [3] Group 3: Innovations in Quality Control - Neurogene and Verve Therapeutics will address modernizing quality control through simplified processes and digital-first execution [3] - Sanofi will showcase the use of AI-powered translation to expedite submission timelines [3] - UCB will share its journey in enterprise eCOA to standardize patient data capture and accelerate delivery [4] Group 4: Veeva's Commitment - Veeva Systems emphasizes its commitment to customer success by providing integrated software, data, and services to advance innovation in the life sciences [4] - The summit serves as a platform for sharing learnings, fresh ideas, and strategies to improve collaboration and accelerate the delivery of novel products [4]